Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GoodRx Holdings, Inc.GDRX · Entity 4838 | Director · 10% owner | March 21, 2025 | March 21, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GoodRx Holdings, Inc.
Report date March 21, 2025 · Filed March 21, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2025-03-21 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-03-21 · Conversion · Acquired 7,000,000 · Balance 7,000,000 F1: On March 21, 2025, the Issuer purchased 7,000,000 shares of Class A common stock from Idea Men, LLC (the "Selling Stockholder") for an aggregate price of $29,400,000 pursuant to the Stock Purchase Agreement dated March 16, 2025 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholder is converting 7,000,000 shares of Class B common stock into Class A common stock on a one-for-one basis. F2: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Row 2 · 2025-03-21 · Disposition to issuer · Disposed 7,000,000 · Balance 0 F1: On March 21, 2025, the Issuer purchased 7,000,000 shares of Class A common stock from Idea Men, LLC (the "Selling Stockholder") for an aggregate price of $29,400,000 pursuant to the Stock Purchase Agreement dated March 16, 2025 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholder is converting 7,000,000 shares of Class B common stock into Class A common stock on a one-for-one basis. |
| Class B Common StockSEC Table II · derivative / convertible security | Direct | 43,164,171 |
Reported balance
After 2025-03-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-03-21 · Conversion · Disposed 7,000,000 · Balance 43,164,171 F2: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: On March 21, 2025, the Issuer purchased 7,000,000 shares of Class A common stock from Idea Men, LLC (the "Selling Stockholder") for an aggregate price of $29,400,000 pursuant to the Stock Purchase Agreement dated March 16, 2025 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholder is converting 7,000,000 shares of Class B common stock into Class A common stock on a one-for-one basis.
F2: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 21, 2025 Filed Mar 21, 2025 16:23 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 7,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000056 · wk-form4_1742588596.xml · derivative · entry 3 Idea Men, LLC · CIK 0001822195 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,164,171 Underlying: Class A Common Stock · 7,000,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F2 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F2 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| March 21, 2025 Filed Mar 21, 2025 16:23 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Disposition to issuerClass A Common Stock | 7,000,000 | $4.20 | $29,400,000.00 |
DisclosureSEC source: 0001809519-25-000056 · wk-form4_1742588596.xml · nonDerivative · entry 2 Idea Men, LLC · CIK 0001822195 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: On March 21, 2025, the Issuer purchased 7,000,000 shares of Class A common stock from Idea Men, LLC (the "Selling Stockholder") for an aggregate price of $29,400,000 pursuant to the Stock Purchase Agreement dated March 16, 2025 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholder is converting 7,000,000 shares of Class B common stock into Class A common stock on a one-for-one basis. Read SEC document |
| March 21, 2025 Filed Mar 21, 2025 16:23 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 7,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-25-000056 · wk-form4_1742588596.xml · nonDerivative · entry 1 Idea Men, LLC · CIK 0001822195 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,000,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: On March 21, 2025, the Issuer purchased 7,000,000 shares of Class A common stock from Idea Men, LLC (the "Selling Stockholder") for an aggregate price of $29,400,000 pursuant to the Stock Purchase Agreement dated March 16, 2025 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholder is converting 7,000,000 shares of Class B common stock into Class A common stock on a one-for-one basis. F2 · price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 18:21 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 2,600 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-001002 · doc4.xml · derivative · entry 3 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,964,171 Underlying: Class A Common Stock · 2,600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 18:21 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 2,600 | $33.05 | $85,927.40 |
DisclosureSEC source: 0000899243-22-001002 · doc4.xml · nonDerivative · entry 2 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020, as amended on September 1, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.15 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 18:21 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 2,600 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-001002 · doc4.xml · nonDerivative · entry 1 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2021 Filed Feb 11, 2022 20:54 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GiftClass B Common Stock · Derivative | 1,800,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-005993 · doc5.xml · derivative · entry 1 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,166,771 Underlying: Class A Common Stock · 1,800,000 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F2 · kind: Represents shares of Class B common stock donated as a gift. No value was received for the gifted shares. F1 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F1 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| December 03, 2021 Filed Dec 3, 2021 19:00 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 166,208 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-046848 · doc4.xml · derivative · entry 15 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,966,771 Underlying: Class A Common Stock · 166,208 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.76 to $38.75 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F11 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F11 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| December 03, 2021 Filed Dec 3, 2021 19:00 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 26,122 | $38.98 | $1,018,282.58 |
DisclosureSEC source: 0000899243-21-046848 · doc4.xml · nonDerivative · entry 12 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020, as amended on September 1, 2021. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.76 to $39.38 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 03, 2021 Filed Dec 3, 2021 19:00 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 50,855 | $38.20 | $1,942,447.41 |
DisclosureSEC source: 0000899243-21-046848 · doc4.xml · nonDerivative · entry 11 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,122 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020, as amended on September 1, 2021. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.76 to $38.75 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 03, 2021 Filed Dec 3, 2021 19:00 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 89,231 | $37.39 | $3,336,391.71 |
DisclosureSEC source: 0000899243-21-046848 · doc4.xml · nonDerivative · entry 10 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,977 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020, as amended on September 1, 2021. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.76 to $37.75 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 03, 2021 Filed Dec 3, 2021 19:00 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 166,208 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-046848 · doc4.xml · nonDerivative · entry 9 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2021 Filed Dec 3, 2021 19:00 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 116,673 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-046848 · doc4.xml · derivative · entry 14 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,132,979 Underlying: Class A Common Stock · 116,673 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.76 to $38.75 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F11 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F11 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| December 02, 2021 Filed Dec 3, 2021 19:00 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 9,422 | $39.73 | $374,355.85 |
DisclosureSEC source: 0000899243-21-046848 · doc4.xml · nonDerivative · entry 8 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020, as amended on September 1, 2021. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.64 to $39.88 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 02, 2021 Filed Dec 3, 2021 19:00 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 45,529 | $38.97 | $1,774,369.85 |
DisclosureSEC source: 0000899243-21-046848 · doc4.xml · nonDerivative · entry 7 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,422 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020, as amended on September 1, 2021. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.60 to $39.59 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 02, 2021 Filed Dec 3, 2021 19:00 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 61,722 | $38.07 | $2,349,503.48 |
DisclosureSEC source: 0000899243-21-046848 · doc4.xml · nonDerivative · entry 6 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,951 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020, as amended on September 1, 2021. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.60 to $38.59 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 02, 2021 Filed Dec 3, 2021 19:00 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 116,673 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-046848 · doc4.xml · nonDerivative · entry 5 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,673 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 19:00 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 226,899 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-046848 · doc4.xml · derivative · entry 13 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,249,652 Underlying: Class A Common Stock · 226,899 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.76 to $38.75 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F11 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F11 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 19:00 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 78,844 | $40.15 | $3,165,665.44 |
DisclosureSEC source: 0000899243-21-046848 · doc4.xml · nonDerivative · entry 4 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020, as amended on September 1, 2021. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.88 to $40.53 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 19:00 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 49,983 | $39.31 | $1,964,976.68 |
DisclosureSEC source: 0000899243-21-046848 · doc4.xml · nonDerivative · entry 3 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,844 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020, as amended on September 1, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.88 to $39.87 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 19:00 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 98,072 | $38.40 | $3,766,317.86 |
DisclosureSEC source: 0000899243-21-046848 · doc4.xml · nonDerivative · entry 2 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,827 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020, as amended on September 1, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.88 to $38.87 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 19:00 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 226,899 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-046848 · doc4.xml · nonDerivative · entry 1 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,899 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2021 Filed Nov 3, 2021 20:31 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 156,132 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-042899 · doc4.xml · derivative · entry 14 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,476,551 Underlying: Class A Common Stock · 156,132 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F9 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F9 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| November 03, 2021 Filed Nov 3, 2021 20:31 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 98,592 | $45.23 | $4,459,247.15 |
DisclosureSEC source: 0000899243-21-042899 · doc4.xml · nonDerivative · entry 11 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020, as amended on September 1, 2021. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.73 to $45.68 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 03, 2021 Filed Nov 3, 2021 20:31 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 44,629 | $44.45 | $1,983,696.57 |
DisclosureSEC source: 0000899243-21-042899 · doc4.xml · nonDerivative · entry 10 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,592 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020, as amended on September 1, 2021. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.72 to $44.70 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 03, 2021 Filed Nov 3, 2021 20:31 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 12,911 | $43.31 | $559,163.79 |
DisclosureSEC source: 0000899243-21-042899 · doc4.xml · nonDerivative · entry 9 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,221 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020, as amended on September 1, 2021. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.66 to $43.62 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 03, 2021 Filed Nov 3, 2021 20:31 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 156,132 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-042899 · doc4.xml · nonDerivative · entry 8 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,132 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 20:31 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 84,025 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-042899 · doc4.xml · derivative · entry 13 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,632,683 Underlying: Class A Common Stock · 84,025 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F9 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F9 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 20:31 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 75 | $43.75 | $3,281.25 |
DisclosureSEC source: 0000899243-21-042899 · doc4.xml · nonDerivative · entry 7 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020, as amended on September 1, 2021. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 20:31 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 16,573 | $42.90 | $711,023.13 |
DisclosureSEC source: 0000899243-21-042899 · doc4.xml · nonDerivative · entry 6 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020, as amended on September 1, 2021. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.75 to $43.60 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 20:31 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 67,377 | $42.39 | $2,856,272.73 |
DisclosureSEC source: 0000899243-21-042899 · doc4.xml · nonDerivative · entry 5 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,648 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020, as amended on September 1, 2021. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.75 to $42.74 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 20:31 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 84,025 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-042899 · doc4.xml · nonDerivative · entry 4 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,025 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:31 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 70,041 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-042899 · doc4.xml · derivative · entry 12 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,716,708 Underlying: Class A Common Stock · 70,041 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F9 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F9 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:31 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 1,900 | $44.77 | $85,056.92 |
DisclosureSEC source: 0000899243-21-042899 · doc4.xml · nonDerivative · entry 3 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020, as amended on September 1, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.59 to $45.05 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:31 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 68,141 | $44.02 | $2,999,839.38 |
DisclosureSEC source: 0000899243-21-042899 · doc4.xml · nonDerivative · entry 2 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,900 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020, as amended on September 1, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.59 to $44.55 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:31 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 70,041 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-042899 · doc4.xml · nonDerivative · entry 1 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 20:22 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 167,557 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-038936 · doc4.xml · derivative · entry 4 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,786,749 Underlying: Class A Common Stock · 167,557 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F4 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F4 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 20:22 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 10,303 | $41.55 | $428,071.10 |
DisclosureSEC source: 0000899243-21-038936 · doc4.xml · nonDerivative · entry 3 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.41 to $41.72 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 20:22 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 157,254 | $41.05 | $6,454,553.33 |
DisclosureSEC source: 0000899243-21-038936 · doc4.xml · nonDerivative · entry 2 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,303 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.41 to $41.40 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 20:22 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 167,557 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-038936 · doc4.xml · nonDerivative · entry 1 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,557 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 29, 2021 Filed Sep 29, 2021 21:08 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 266,726 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-038249 · doc4.xml · derivative · entry 13 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,954,306 Underlying: Class A Common Stock · 266,726 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F9 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F9 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| September 29, 2021 Filed Sep 29, 2021 21:08 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 145,529 | $40.78 | $5,934,963.68 |
DisclosureSEC source: 0000899243-21-038249 · doc4.xml · nonDerivative · entry 10 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.43 to $41.28 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 29, 2021 Filed Sep 29, 2021 21:08 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 121,197 | $39.95 | $4,841,747.43 |
DisclosureSEC source: 0000899243-21-038249 · doc4.xml · nonDerivative · entry 9 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,529 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.43 to $40.42 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 29, 2021 Filed Sep 29, 2021 21:08 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 266,726 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-038249 · doc4.xml · nonDerivative · entry 8 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,726 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 28, 2021 Filed Sep 29, 2021 21:08 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 322,941 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-038249 · doc4.xml · derivative · entry 12 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,221,032 Underlying: Class A Common Stock · 322,941 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F9 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F9 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| September 28, 2021 Filed Sep 29, 2021 21:08 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 9,900 | $41.93 | $415,062.45 |
DisclosureSEC source: 0000899243-21-038249 · doc4.xml · nonDerivative · entry 7 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.69 to $42.01 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 28, 2021 Filed Sep 29, 2021 21:08 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 28,787 | $41.01 | $1,180,551.99 |
DisclosureSEC source: 0000899243-21-038249 · doc4.xml · nonDerivative · entry 6 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,900 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.63 to $41.47 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 28, 2021 Filed Sep 29, 2021 21:08 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 284,254 | $40.15 | $11,413,053.93 |
DisclosureSEC source: 0000899243-21-038249 · doc4.xml · nonDerivative · entry 5 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,687 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 25, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.63 to $40.62 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 28, 2021 Filed Sep 29, 2021 21:08 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 322,941 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-038249 · doc4.xml · nonDerivative · entry 4 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,941 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 27, 2021 Filed Sep 29, 2021 21:08 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 291,244 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-038249 · doc4.xml · derivative · entry 11 Idea Men, LLC · CIK 0001822195 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,543,973 Underlying: Class A Common Stock · 291,244 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F9 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F9 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such shares of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.